TuHURA Biosciences
HURA
17 hedge funds and large institutions have $219K invested in TuHURA Biosciences in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
330% more capital invested
Capital invested by funds: $51K → $219K (+$168K)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
31% more funds holding
Funds holding: 13 → 17 (+4)
0.01% more ownership
Funds ownership: 0.04% → 0.04% (+0.01%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$53.5K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$13.2K |
| 3 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
+$7.94K |
| 4 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$7.59K |
| 5 |
CCFM
Clear Creek Financial Management
Silverdale,
Washington
|
+$4.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11.2K |
| 2 |
HF
HRT Financial
New York
|
-$8K |
| 3 |
Jane Street
New York
|
-$3.82K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.94K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.28K |
HURA Hedge Fund Activity: Q2 2024 in Review
17 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2024, worth a combined $219K — up 330% from $51K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new HURA positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $53.5K. The largest seller was UBS Group, cutting an estimated $11.2K.
- 17 institutional investors held TuHURA Biosciences (HURA) as of Q2 2024, up from 13 in Q1 2024.
- Funds reported $219K of TuHURA Biosciences stock for Q2 2024, up 330% quarter-over-quarter.
- 7 funds opened new TuHURA Biosciences positions in Q2 2024 and 3 closed out, a net change of +4 holders.
- The largest TuHURA Biosciences buyer in Q2 2024 was Geode Capital Management, an estimated $53.5K added.
- The largest TuHURA Biosciences seller in Q2 2024 was UBS Group, an estimated $11.2K sold.
Based on aggregated 13F filings for Q2 2024.